CanVECTOR and Thrombosis Canada Conferences November 7

Thrombosis Unpacked: Decisions That Matter November 7, 2026 Join healthcare professionals from across Canada in Montreal for two days of practical, multidisciplinary education focused on difficult thrombosis and anticoagulation decisions encountered in real-world clinical care. The 2026 CanVECTOR and Thrombosis Canada Conferences bring together clinicians, researchers, pharmacists, nurses, and healthcare professionals to explore evolving evidence, controversial […]

Comments (0)

Events

Oct 27 2026

george

Laboratory Diagnostics for Thrombosis and Hemostasis Testing

Here is a detailed introduction to the fifth “Seminars in Hemostasis and Thrombosis” issue devoted to laboratory testing: Smock KJ, Moffat KA. Laboratory diagnostics for thrombosis and hemostasis testing-Part V. Semin Thromb Hemost. 2026;52(8):887-888. doi: 10.1055/a-2912-7667. PMID: 42913665. The 14 citations are available as open-access articles.

Events

A Coag Conversation: 100 Years of VWD and Upcoming Advances: Conversation 3

On August 11, 2026, we posted the third and concluding conversation of “100 Years of Von Willebrand Disease and Upcoming Advances” with Robert F. Sidonio, Jr., MD, MSc. Click here for #3: Advanced Assays and von Willebrand Disease Management.

Bleeding Disorders

ISTH Paris Summary

Thanks to Dr. Ali Sadeghi-Khomami, PBI Research Scientist, for this downloadable comprehensive summary of the ISTH meeting in Paris.

Events

Events and Conferences: Bleeding Disorders Conference August 13–15

Thanks to Elaine Benoit, PBI’s marketing guru, for recent updates to our Events and Conferences Calendar. This week is the NBDF’s Bleeding Disorders Conference in Orlando, FL, USA, August 13–15. It’s not too late to register. Our colleagues at George King Bio-Medical will exhibit at booth 100. If you don’t see your hemostasis-related event or […]

Events

ASH Coagulation Presentation Overview

The 67th ASH Annual Meeting is December 6–9 in Orlando, FL, USA. Here’s Dr. Wolfgang Miesback’s list of bleeding disorder presentations.

Bleeding Disorders

Gene Transfer Therapy Updates

Yesterday, 10-28-25, we reported BioMarin’s press release announcing divestiture of their hemophilia A gene transfer therapy, valoctocogene roxaparvovec (Roctavian®). Previously, on February 25, 2025, Pfizer announced their intention to discontinue hemophilia B gene transfer therapy, fidanacogene elaparvovec-dzkt (Becvez®). Press releases from both indicate underperformance in sales. The remaining hemophilia B therapy, etranacogene dezaparvovec-drlb (HEMGENIX®), CSL […]

Bleeding Disorders

BioMarin Plans to Divest Struggling Gene Therapy

Thanks to Dean Willett of Precision BioLogic Inc. for the heads-up on BioMarin’s 10-27-25 post announcing their divestment of the hemophilia A gene transfer therapy, Roctavian. See BioMarin’s 10-27 press release.

Bleeding Disorders

A Coag Conversation: Alternate Warfarin Monitoring When the Prothrombin Time is Unreliable – Part 1

Join me (Geo) and guest speaker Dr. Nicole Zantek, MD, PhD, Medical Director of the Special Coagulation Laboratory, Professor, Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, who discusses the pathophysiology of antiphospholipid antibodies, and alternative methods to monitor warfarin and DOAC anticoagulation in patients diagnosed with antiphospholipid syndrome. This is the […]

Comments (0)

Anticoagulant Therapy

Jun 28 2025

george

Differential Discussion: Hemophilia Part 2

On June 6, 2025, Malissa Norfolk and Dave Cabral posted George’s audio PowerPoint, “Have We Cured Hemophilia, Part 1?.” On June 25, Malissa and Dave posted “Have We Cured Hemophilia, Part 2?” Each video is 30″ long. Please feel free to watch and comment below.

Comments (0)

Bleeding Disorders

Events

CanVECTOR and Thrombosis Canada Conferences November 7

Laboratory Diagnostics for Thrombosis and Hemostasis Testing

A Coag Conversation: 100 Years of VWD and Upcoming Advances: Conversation 3

ISTH Paris Summary

Events and Conferences: Bleeding Disorders Conference August 13–15

ASH Coagulation Presentation Overview

Gene Transfer Therapy Updates

BioMarin Plans to Divest Struggling Gene Therapy

A Coag Conversation: Alternate Warfarin Monitoring When the Prothrombin Time is Unreliable – Part 1

Differential Discussion: Hemophilia Part 2

George Fritsma MS MLS

Cheat Sheets from George

Questions or Comments?

Quick Question